Seizing $45.66 Billion Opportunity in the Antibody-drug Conjugate Landscape
From Fragmented Supply Chains to Integrated ADC Solutions: What’s Driving Transformation in the Biopharmaceutical Industry
Antibody-drug conjugate (ADC) contract development and manufacturing organizations (CDMOs) are shaping the future of oncology therapeutics. With the ADC market expanding rapidly, sponsors are under pressure to scale manufacturing while managing complex payloads, conjugation and drug-to-antibody ratio (DAR) control, evolving regulatory requirements, and multi-region supply chains.
Frost & Sullivan’s latest analysis, Frost Radar™: Antibody-drug Conjugate Contract Development and Manufacturing Organizations, highlights the leaders and innovators redefining ADC development and manufacturing through proprietary platforms, advanced process analytics, and fully integrated services.
Download Now
What This Analysis Reveals for Biopharma Executives
- Innovative Business Models: See how end-to-end offerings–from antibody production to sterile fill-finish–reduce handoffs, de-risk scale-up, and ensure reliable ADC supply.
- Competitive Benchmarking: Compare leading ADC CDMOs to see how proprietary platforms and integrated capabilities differentiate top partners through innovation and operational excellence.
- Growth Opportunities: Explore emerging opportunities in next-gen conjugated biologics, including antibody-oligonucleotide conjugates (AOCs) and antibody-radionuclide conjugates (ARCs).
- Strategic Insights: Identify investment priorities, adoption strategies, and regulatory milestones across key markets including the USA, China, Europe, and India.
Discover who’s leading the revolution and how your organization can partner with top ADC CDMOs to capture the next wave of growth.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
Upon completing the dialog session, you will receive a $1,000 honorarium as a token of our appreciation, which can be used towards the purchase of our products or services.
